It's an excellent book and I highly recommend it.
Vendor marketing exists in all fields, technology included. The difference is that when I'm spending money on a vendor as a tech manager it's coming out of my budget. I have an incentive to make sure that the spending is intelligent and the solution is effective.
Where is the incentive for doctors to do that? They're spending other people's money on other people's problems.
As a tech manager, you're not using your personal funds, either, you're using your employer's money.
Further, if a doctor's prescription doesn't work, or is too expensive, the patients can get a second opinion, and the doctor can lose the person as a patient. An employer may not even have that option with a tech manager.
Right, but I am spending the money of my company. They control my salary and advancement, and I also have a fixed pool to draw from.
Doctors are spending money for insurance companies.
The insurance company can investigate the efficacy of prescriptions and stop paying for ones that don't work. The article says some of them have done exactly that with Oxycontin.
At the other end, if the pain killer isn't working, a patient can go to a different doctor who will prescribe something else.
It's sorta similar to the function congressional lobbying is supposed to fulfill. Ie. It'd be ideal if the congressmen/doctors did all the research themselves but that's not possible so you basically have a whole research team at your disposal (who's agenda is very obvious...)
"Instead of relying on marketing, I rely on information from good, well performed randomised controlled studies published in reputable peer reviewed journals ( I like the NEJM ) and on meta-analyses of these. I view the results of these through a filter of scepticism, cynicism, pragmatism and a modicum of hope."
> how could they get you to read about it?
I'd assume by performing a sensible clinical trial that proves its efficacy beyond a reasonable doubt.
Advertising is how you're sold things whether or not you need them. It is not how you learn about what's best for your patient. There are other avenues of information that aren't tainted by the motivation to sell a product despite the consequences.
That sounds similar to Suboxone, just with OxyCodone instead of Buprenorphine (i think they also make bup. minus the naloxone under the brand name Subutex). The naloxone mixture never quite made sense to me. Isn't that counter-productive? Is naloxone (aka "Narcan") not an opioid-antagonist at low doses or something?
This marketing says it's in the Targin to reduce constipation:
I'm a layman, but if i'm guessing right the term for this might be 'bioavailability' of the drug, is that correct? for example drug A may be absorbed faster and more easily through the digestive system over snorting. And then of course IV is the quickest way for just about anything, yea?
Your example however makes an incorrect assumption. Bioavailability from snorting a powdered drug is higher than oral ingestion. When snorted, the drug passes through the thin lining of the nose and enters the bloodstream directly. When ingested orally, the drug has to make it through the chaos of the stomach and small intestine, get through the hepatic pathway (stomach and intestinal lining to liver to general bloodstream) before it reaches the rest of the body.
Even if they only influence 1 doctor in a hundred, but that doctor brings enough revenue, it's worth it.
What? Are they allowed to just enter hospitals as neither doctor, patient, nor visitor, and hang around promoting their companies' drugs? If so, why??
I get large amounts of ad-junk from drug companies that ends up unread in the bin. I refuse to meet with drug company representatives. I smile politely at them if I bump into them in the corridor and suggest that they leave their ad-junk with my secretary. My staff then file their ad-junk in the trash bin.
On Friday, I had a drug company representative attempt to tell me ( he was hanging around my coffee area ) about the joys of Targin, a fixed-dose combination of oxycodone and naloxone. I gently shook him off, and directed him to my secretary.
Drug company representatives are usually decent human beings with lives and families. However they are poorly educated, poorly informed salesmen and women with sales targets to meet and product managers to keep happy. Even worse, they and the drug company have no accountability if a patient dies because of their recommendations. If avoidable death supervenes or if there are non-lethal complications or even just therapeutic failure, I am accountable.
Instead of relying on marketing, I rely on information from good, well performed randomised controlled studies published in reputable peer reviewed journals ( I like the NEJM ) and on meta-analyses of these. I view the results of these through a filter of scepticism, cynicism, pragmatism and a modicum of hope.
Many of my colleagues do likewise. I trust that you do the same in your respective vocations. Regrettably, there is a bell curve. I am sure that the drug companies find enough gullible prescribers out in the wild for their purposes.